BMIVPOT, a Fully Automated Version of the Intravenous Pole: Simulation, Design, and Evaluation.

Robotic intravenous poles are automated supportive instrument that needs to be triggered by patients to hold medications and needed supplies. Healthcare engineering of robotic intravenous poles is advancing in order to improve the quality of health services to patients worldwide. Existing intravenous poles in the market were supportive to patients, yet they constrained their movement, consumed the time of both the patient and the nurse, and they were expensive in regard to what they offer. Although robotic poles overcame some of the movement limitations of the commercial/market poles, they were partially automated and did not offer additional technological features. The aim of our work was to develop a fully automated Biomedical Intravenous Pole Robot (BMIVPOT) to resolve the aforementioned limitations and to offer new technological features to intravenous poles, thereby promoting the health services. Several sensors and build-up materials were empirically chosen to be cost-effective and fulfill our needs. The new prototype was divided into three steps: simulated prototype, real implementation of the prototype, and testing and evaluation. Simulation results showed the best qualitative way to fit all the specifications in the robotic system, such as the shape, sensors, and connections in order to provide the proper functionality of the system. Experimental and real results provided the manufactured parts, implemented sensors, and the final robot. Testing the tracking and the flow sensor performances were provided. Evaluation of our Biomedical Intravenous Pole Robot with alternatives showed that our robot outperforms the other poles in many aspects including the features it offers, the percentage of interventions it comprised, the reliability, and cost-effectiveness. The overall percentage of features offered by our Biomedical Intravenous Pole Robot was 60% higher than that offered by peer research poles and 80% higher than that of the market poles. In addition, the average percentage of integration of interventions (architecture, sensor, wireless, tracking, and mechanical) in the Biomedical Intravenous Pole Robot was at least 56% higher than that of the alternative poles. According to the results, Biomedical Intravenous Pole Robot offers a cost-effective price as compared to the others. As a future prospect, we intend to add more features to this prototype in order to enhance it, such as vital signs detection, and improve the tracking system.

Effect of clonidine versus dexmedetomidine on pain control after laparoscopic gastric sleeve: A prospective, randomized, double-blinded study.

BACKGROUND: The use of opioids in surgeries for morbidly obese patients could cause respiratory depression. Therefore, alternative analgesics are needed to improve anesthetic management for obese patients. The objective of this study was to compare the effect of dexmedetomidine and clonidine on pain as well as analgesic consumption at 24 h postoperatively in patients undergoing laparoscopic gastric sleeve. The secondary objective was to compare patients' and surgeons' satisfaction. MATERIALS AND METHODS: A total of 60 obese and morbidly obese patients scheduled to undergo laparoscopic gastric sleeve were randomly assigned into two groups. 10 min after induction of general anesthesia, one group received 0.8-1.2 µg/kg/30 min intravenous (IV) clonidine through 500 mL lactated Ringer's solution and placebo (normal saline solution) through syringe pump. The second group received IV dexmedetomidine through syringe pump at a rate 0.5-0.8 µg/kg/h and placebo through 500 mL lactated Ringer's solution. Data on pain, analgesic consumption, and return to normal activity in addition to patients' and surgeons' satisfaction were collected. RESULTS: Both groups were similar with respect to demographic and intraoperative hemodynamic characteristics. Fentanyl consumption, surgery duration and hospital stay were similar for the two groups. Pain scores on walking were significantly lower in the clonidine group at 12 h postoperatively (P = 0.014) compared with dexmedetomidine group. The number of patients who consumed pethidine was significantly lower in the clonidine group at 12 h postoperatively (P = 0.045). CONCLUSION: This study concluded that clonidine and dexmedetomidine yielded similar outcomes with a difference in pain and analgesic consumption at 12 h postoperatively.

Hydrazine borane-induced destabilization of ammonia borane, and vice versa.

In the field of solid-state chemical hydrogen storage, ammonia borane NH3BH3 has been widely studied while hydrazine borane N2H4BH3 can be considered as a "novel" material. In the present work, we investigated the behaviour of these boranes when mixed together in a mole ratio of 1:1. Hydrazine borane and ammonia borane destabilize each other. Though stable at 20-25 °C, the mixture melts at ∼ 30 °C and then undergoes significant decomposition, with desorption of hydrogen H2 and hydrazine N2H4 from 67 °C. This is explained by the fact that the presence of hydrazine borane disrupts the H(δ+)⋯ H(δ-) network of ammonia borane, and vice versa; the mixture is then much less stable than the pristine boranes. The mixture can nevertheless be stabilized (by heat- or vacuum-treatment and thus extraction of evolving hydrogen and hydrazine), making the as-obtained solid a potential chemical hydrogen storage material. Over the range 25-300 °C, it is able to release ca. 11.4 wt% of almost pure H2. Furthermore forms boron nitride as the solid residue, at temperatures as low as 300 °C.

Hydrazine borane: synthesis, characterization, and application prospects in chemical hydrogen storage.

Hydrazine borane (N(2)H(4)BH(3)) is the novel boron- and nitrogen-based material appearing to be a promising candidate in chemical hydrogen storage. It stores 15.4 wt% of hydrogen in hydridic and protic forms, and the challenge is to release H(2) with maximum efficiency, if possible all hydrogen stored in the material. An important step to realize this ambitious goal is to synthesize HB with high yields and high purity, and to characterize it fully. In this work, we report a 2-step synthesis (salt metathesis and solvent extraction-drying) through which N(2)H(4)BH(3) is successfully obtained in 3 days, with a yield of about 80% and a purity of 99.6%. N(2)H(4)BH(3) was characterized by NMR, IR, XRD, TGA and DSC, its stability in dioxane and water was determined, and its thermolysis by-products were characterized. We thus present a complete data sheet that should be very useful for future studies. Furthermore, we propose a discussion on the potential of HB (with H(2) released by either thermolysis or hydrolysis) in chemical hydrogen storage.